Displaying 1 - 20 of 1949
Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin)
The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
Kroger Company/Albertsons Companies, Inc., In the Matter of
The Federal Trade Commission sued to block the largest proposed supermarket merger in U.S. history—Kroger Company’s $24.6 billion acquisition of the Albertsons Companies, Inc.—alleging that the deal is anticompetitive.
FTC Statement on Appellate Court Decision Ordering Delisting of Teva Inhaler Patents
FTC Approves Final Order against Rytr, Seller of an AI “Testimonial & Review” Service, for Providing Subscribers with Means to Generate False and Deceptive Reviews
Southern Glazer's Wine and Spirits, LLC., FTC v.
The Federal Trade Commission sued the largest U.S. distributor of wine and spirits—Southern Glazer’s Wine and Spirits, LLC (Southern)—alleging the company violated the Robinson-Patman Act, harming small, independent businesses by depriving them of access to discounts and rebates, and impeding their ability to compete against large national and regional chains. This loss of competition ultimately harms consumers on choice and price.